| [1] |
Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association; Nutrition and Regeneration in End-Stage Liver Disease Group, Chinese Society of Hepatology, Chinese Medical Association.
Guidelines for the diagnosis and treatment of acute-on-chronic liver failure (2025 version)
[J]. Journal of Practical Hepatology, 2025, 28(5): 641-647.
|
| [2] |
Du Bingyu, Li Junfeng, Zhang Liting.
Early diagnosis and treatment of patients with acute-on-chronic liver failure complicated with acute kidney injury
[J]. Journal of Practical Hepatology, 2025, 28(5): 797-800.
|
| [3] |
Yan Lichun, Zhang Kai, Liang Xiaowei.
ACY1215, a histone deacetylase inhibitor, protects mice from acute liver failure by regulating liver tissue PANoptosis expression
[J]. Journal of Practical Hepatology, 2025, 28(4): 505-508.
|
| [4] |
Li Yongfei, Xu Zhengju, Ye Qiaoxia, et al.
Efficacy of plasma exchange and hemofiltration in the treatment of patients with acute-on-chronic hepatitis B liver failure
[J]. Journal of Practical Hepatology, 2025, 28(3): 394-397.
|
| [5] |
Zhang Wenrui, Zhao Ninghui, Yao Ruoyu, et al.
Comparison of nafamostat mesylate and unfractionated heparin for anticoagulation during double plasma molecular adsorption system treatment in patients with liver failure
[J]. Journal of Practical Hepatology, 2025, 28(3): 398-401.
|
| [6] |
Ban Lingwei, Yang Qinbing, Hua Xin.
Subjective global assessment and global leaders malnutrition initiative standards in the assessment of malnutrition in patients with liver failure
[J]. Journal of Practical Hepatology, 2025, 28(2): 226-229.
|
| [7] |
Guo Jianhui, Zhou Yongbing, He Qin.
Changes of serum sST2, TLR4, suPAR and Beclin1 levels in patients with HBV-related acute-on-chronic liver failure
[J]. Journal of Practical Hepatology, 2025, 28(2): 230-233.
|
| [8] |
Li Shiwei, Li Jiaguo, Zhu Jing, et al.
Serum ANGPTL2, sVAP-1 and HMGB1 level changes in patients with hepatitis B virus infection-related acute-on-chronic liver failure
[J]. Journal of Practical Hepatology, 2025, 28(2): 234-237.
|
| [9] |
Shen Qiyan, Zhang Long, Zhang Yanqiong, et al.
Protection of CAY10602, a SIRT1 agonist, on liver injuries in mice with LPS/D-Gal-induced acute liver failure
[J]. Journal of Practical Hepatology, 2025, 28(1): 20-23.
|
| [10] |
Feng Shun, Zhao Lei, Zhang Lijuan.
Serum human beta-defensin-1, Golgi protein 73 and interleukin-33 level changes in patients with hepatitis B-induced acute-on-chronic liver failure
[J]. Journal of Practical Hepatology, 2025, 28(1): 80-83.
|
| [11] |
Sun Min, Zhang Qian, Xu Gang, et al.
Prevalence and risk factors of pulmonary infection in patients with acute-on-chronic liver failure
[J]. Journal of Practical Hepatology, 2025, 28(1): 84-87.
|
| [12] |
Zhang Xiaoya, Shi Chunxia, Guo Jin, et al.
Mechanism of histone deacetylase inhibitor ACY1215 in inhibition of LPS/D-galactosamine-induced acute liver failure in mice
[J]. Journal of Practical Hepatology, 2024, 27(6): 812-815.
|
| [13] |
Xu Manman, Yang Yanrong, Li Shanshan, et al.
Trends in outcomes of patients with liver failure in our hospital over the past ten years
[J]. Journal of Practical Hepatology, 2024, 27(6): 874-877.
|
| [14] |
Qiu Zhongqiong, Lin Jianhui, Weng Yanyan, et al.
Factors impacting prognosis of patients with acute-on-chronic hepatitis B liver failure complicated by hospital-acquired pneumonia
[J]. Journal of Practical Hepatology, 2024, 27(6): 878-881.
|
| [15] |
Wu Yu, Han Yuxing, Xu Manman, et al.
Hospital profit and deficit of medical costs in patients with acute-on-chronic liver failure based on DRG payment reform
[J]. Journal of Practical Hepatology, 2024, 27(6): 882-886.
|
